Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Godinho

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAsBruno M D C Godinho, Emily G Knox, Samuel Hildebrand, et al.
Frontiers in Immunology|May 27, 2026
Shaping the founders: naïve CD4 T cell heterogeneity in people with HIV-1 or HIV-2Robert Badura, Nicole C Martins, Guilherme B Farias, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Nucleic Acids Research|February 13, 2018
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivoMatthew R Hassler, Anton A Turanov, Julia F Alterman, et al.
Nature Biotechnology|November 20, 2018
RNAi modulation of placental sFLT1 for the treatment of preeclampsiaAnton A Turanov, Agnes Lo, Matthew R Hassler, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Scientific Reports|January 24, 2024
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 miceRachelle Driscoll, Lucas Hampton, Neeta A Abraham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Molecular Therapy. Nucleic Acids|September 5, 2024
Identification of selective and non-selective <i>C9ORF72</i> targeting <i>in vivo</i> active siRNAsJames W Gilbert, Zachary Kennedy, Bruno M D C Godinho, et al.
Molecular Therapy. Nucleic Acids|July 7, 2022
PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAsBruno M D C Godinho, Emily G Knox, Samuel Hildebrand, et al.
Frontiers in Immunology|May 27, 2026
Shaping the founders: naïve CD4 T cell heterogeneity in people with HIV-1 or HIV-2Robert Badura, Nicole C Martins, Guilherme B Farias, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Nucleic Acids Research|February 13, 2018
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivoMatthew R Hassler, Anton A Turanov, Julia F Alterman, et al.
Nature Biotechnology|November 20, 2018
RNAi modulation of placental sFLT1 for the treatment of preeclampsiaAnton A Turanov, Agnes Lo, Matthew R Hassler, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Scientific Reports|January 24, 2024
Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 miceRachelle Driscoll, Lucas Hampton, Neeta A Abraham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Pageof 7